Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson’s disease
The proximity ligation assay (PLA) is a specific and sensitive technique for the detection of αSyn oligomers (αSyn-PLA), early and toxic species implicated in the pathogenesis of PD. We aimed to evaluate by skin biopsy the diagnostic and prognostic capacity of αSyn-PLA and small nerve fiber reductio...
Uložené v:
| Vydané v: | NPJ Parkinson's Disease Ročník 7; číslo 1; s. 119 - 11 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
Nature Publishing Group UK
20.12.2021
Nature Publishing Group Nature Portfolio |
| Predmet: | |
| ISSN: | 2373-8057, 2373-8057 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | The proximity ligation assay (PLA) is a specific and sensitive technique for the detection of αSyn oligomers (αSyn-PLA), early and toxic species implicated in the pathogenesis of PD. We aimed to evaluate by skin biopsy the diagnostic and prognostic capacity of αSyn-PLA and small nerve fiber reduction in PD in a longitudinal study. αSyn-PLA was performed in the ankle and cervical skin biopsies of PD (
n
= 30), atypical parkinsonisms (AP,
n
= 23) including multiple system atrophy (MSA,
n
= 12) and tauopathies (AP-Tau,
n
= 11), and healthy controls (HC,
n
= 22). Skin biopsy was also analyzed for phosphorylated αSyn (P-αSyn) and 5G4 (αSyn-5G4), a conformation-specific antibody to aggregated αSyn. Intraepidermal nerve fiber density (IENFD) was assessed as a measure of small fiber neuropathy. αSyn-PLA signal was more expressed in PD and MSA compared to controls and AP-Tau. αSyn-PLA showed the highest diagnostic accuracy (PD vs. HC sensitivity 80%, specificity 77%; PD vs. AP-Tau sensitivity 80%, specificity 82%), however, P-αSyn and 5G4, possible markers of later phases, performed better when considering the ankle site alone. A small fiber neuropathy was detected in PD and MSA. A progression of denervation not of pathological αSyn was detected at follow-up and a lower IENFD at baseline was associated with a greater cognitive and motor decline in PD. A skin biopsy-derived compound marker, resulting from a linear discrimination analysis model of αSyn-PLA, P-αSyn, αSyn-5G4, and IENFD, stratified patients with accuracy (77.8%), including the discrimination between PD and MSA (84.6%). In conclusion, the choice of pathological αSyn marker and anatomical site influences the diagnostic performance of skin biopsy and can help in understanding the temporal dynamics of αSyn spreading in the peripheral nervous system during the disease. Skin denervation, not pathological αSyn is a potential progression marker for PD. |
|---|---|
| AbstractList | The proximity ligation assay (PLA) is a specific and sensitive technique for the detection of αSyn oligomers (αSyn-PLA), early and toxic species implicated in the pathogenesis of PD. We aimed to evaluate by skin biopsy the diagnostic and prognostic capacity of αSyn-PLA and small nerve fiber reduction in PD in a longitudinal study. αSyn-PLA was performed in the ankle and cervical skin biopsies of PD (n = 30), atypical parkinsonisms (AP, n = 23) including multiple system atrophy (MSA, n = 12) and tauopathies (AP-Tau, n = 11), and healthy controls (HC, n = 22). Skin biopsy was also analyzed for phosphorylated αSyn (P-αSyn) and 5G4 (αSyn-5G4), a conformation-specific antibody to aggregated αSyn. Intraepidermal nerve fiber density (IENFD) was assessed as a measure of small fiber neuropathy. αSyn-PLA signal was more expressed in PD and MSA compared to controls and AP-Tau. αSyn-PLA showed the highest diagnostic accuracy (PD vs. HC sensitivity 80%, specificity 77%; PD vs. AP-Tau sensitivity 80%, specificity 82%), however, P-αSyn and 5G4, possible markers of later phases, performed better when considering the ankle site alone. A small fiber neuropathy was detected in PD and MSA. A progression of denervation not of pathological αSyn was detected at follow-up and a lower IENFD at baseline was associated with a greater cognitive and motor decline in PD. A skin biopsy-derived compound marker, resulting from a linear discrimination analysis model of αSyn-PLA, P-αSyn, αSyn-5G4, and IENFD, stratified patients with accuracy (77.8%), including the discrimination between PD and MSA (84.6%). In conclusion, the choice of pathological αSyn marker and anatomical site influences the diagnostic performance of skin biopsy and can help in understanding the temporal dynamics of αSyn spreading in the peripheral nervous system during the disease. Skin denervation, not pathological αSyn is a potential progression marker for PD. The proximity ligation assay (PLA) is a specific and sensitive technique for the detection of αSyn oligomers (αSyn-PLA), early and toxic species implicated in the pathogenesis of PD. We aimed to evaluate by skin biopsy the diagnostic and prognostic capacity of αSyn-PLA and small nerve fiber reduction in PD in a longitudinal study. αSyn-PLA was performed in the ankle and cervical skin biopsies of PD ( n = 30), atypical parkinsonisms (AP, n = 23) including multiple system atrophy (MSA, n = 12) and tauopathies (AP-Tau, n = 11), and healthy controls (HC, n = 22). Skin biopsy was also analyzed for phosphorylated αSyn (P-αSyn) and 5G4 (αSyn-5G4), a conformation-specific antibody to aggregated αSyn. Intraepidermal nerve fiber density (IENFD) was assessed as a measure of small fiber neuropathy. αSyn-PLA signal was more expressed in PD and MSA compared to controls and AP-Tau. αSyn-PLA showed the highest diagnostic accuracy (PD vs. HC sensitivity 80%, specificity 77%; PD vs. AP-Tau sensitivity 80%, specificity 82%), however, P-αSyn and 5G4, possible markers of later phases, performed better when considering the ankle site alone. A small fiber neuropathy was detected in PD and MSA. A progression of denervation not of pathological αSyn was detected at follow-up and a lower IENFD at baseline was associated with a greater cognitive and motor decline in PD. A skin biopsy-derived compound marker, resulting from a linear discrimination analysis model of αSyn-PLA, P-αSyn, αSyn-5G4, and IENFD, stratified patients with accuracy (77.8%), including the discrimination between PD and MSA (84.6%). In conclusion, the choice of pathological αSyn marker and anatomical site influences the diagnostic performance of skin biopsy and can help in understanding the temporal dynamics of αSyn spreading in the peripheral nervous system during the disease. Skin denervation, not pathological αSyn is a potential progression marker for PD. Abstract The proximity ligation assay (PLA) is a specific and sensitive technique for the detection of αSyn oligomers (αSyn-PLA), early and toxic species implicated in the pathogenesis of PD. We aimed to evaluate by skin biopsy the diagnostic and prognostic capacity of αSyn-PLA and small nerve fiber reduction in PD in a longitudinal study. αSyn-PLA was performed in the ankle and cervical skin biopsies of PD (n = 30), atypical parkinsonisms (AP, n = 23) including multiple system atrophy (MSA, n = 12) and tauopathies (AP-Tau, n = 11), and healthy controls (HC, n = 22). Skin biopsy was also analyzed for phosphorylated αSyn (P-αSyn) and 5G4 (αSyn-5G4), a conformation-specific antibody to aggregated αSyn. Intraepidermal nerve fiber density (IENFD) was assessed as a measure of small fiber neuropathy. αSyn-PLA signal was more expressed in PD and MSA compared to controls and AP-Tau. αSyn-PLA showed the highest diagnostic accuracy (PD vs. HC sensitivity 80%, specificity 77%; PD vs. AP-Tau sensitivity 80%, specificity 82%), however, P-αSyn and 5G4, possible markers of later phases, performed better when considering the ankle site alone. A small fiber neuropathy was detected in PD and MSA. A progression of denervation not of pathological αSyn was detected at follow-up and a lower IENFD at baseline was associated with a greater cognitive and motor decline in PD. A skin biopsy-derived compound marker, resulting from a linear discrimination analysis model of αSyn-PLA, P-αSyn, αSyn-5G4, and IENFD, stratified patients with accuracy (77.8%), including the discrimination between PD and MSA (84.6%). In conclusion, the choice of pathological αSyn marker and anatomical site influences the diagnostic performance of skin biopsy and can help in understanding the temporal dynamics of αSyn spreading in the peripheral nervous system during the disease. Skin denervation, not pathological αSyn is a potential progression marker for PD. The proximity ligation assay (PLA) is a specific and sensitive technique for the detection of αSyn oligomers (αSyn-PLA), early and toxic species implicated in the pathogenesis of PD. We aimed to evaluate by skin biopsy the diagnostic and prognostic capacity of αSyn-PLA and small nerve fiber reduction in PD in a longitudinal study. αSyn-PLA was performed in the ankle and cervical skin biopsies of PD (n = 30), atypical parkinsonisms (AP, n = 23) including multiple system atrophy (MSA, n = 12) and tauopathies (AP-Tau, n = 11), and healthy controls (HC, n = 22). Skin biopsy was also analyzed for phosphorylated αSyn (P-αSyn) and 5G4 (αSyn-5G4), a conformation-specific antibody to aggregated αSyn. Intraepidermal nerve fiber density (IENFD) was assessed as a measure of small fiber neuropathy. αSyn-PLA signal was more expressed in PD and MSA compared to controls and AP-Tau. αSyn-PLA showed the highest diagnostic accuracy (PD vs. HC sensitivity 80%, specificity 77%; PD vs. AP-Tau sensitivity 80%, specificity 82%), however, P-αSyn and 5G4, possible markers of later phases, performed better when considering the ankle site alone. A small fiber neuropathy was detected in PD and MSA. A progression of denervation not of pathological αSyn was detected at follow-up and a lower IENFD at baseline was associated with a greater cognitive and motor decline in PD. A skin biopsy-derived compound marker, resulting from a linear discrimination analysis model of αSyn-PLA, P-αSyn, αSyn-5G4, and IENFD, stratified patients with accuracy (77.8%), including the discrimination between PD and MSA (84.6%). In conclusion, the choice of pathological αSyn marker and anatomical site influences the diagnostic performance of skin biopsy and can help in understanding the temporal dynamics of αSyn spreading in the peripheral nervous system during the disease. Skin denervation, not pathological αSyn is a potential progression marker for PD.The proximity ligation assay (PLA) is a specific and sensitive technique for the detection of αSyn oligomers (αSyn-PLA), early and toxic species implicated in the pathogenesis of PD. We aimed to evaluate by skin biopsy the diagnostic and prognostic capacity of αSyn-PLA and small nerve fiber reduction in PD in a longitudinal study. αSyn-PLA was performed in the ankle and cervical skin biopsies of PD (n = 30), atypical parkinsonisms (AP, n = 23) including multiple system atrophy (MSA, n = 12) and tauopathies (AP-Tau, n = 11), and healthy controls (HC, n = 22). Skin biopsy was also analyzed for phosphorylated αSyn (P-αSyn) and 5G4 (αSyn-5G4), a conformation-specific antibody to aggregated αSyn. Intraepidermal nerve fiber density (IENFD) was assessed as a measure of small fiber neuropathy. αSyn-PLA signal was more expressed in PD and MSA compared to controls and AP-Tau. αSyn-PLA showed the highest diagnostic accuracy (PD vs. HC sensitivity 80%, specificity 77%; PD vs. AP-Tau sensitivity 80%, specificity 82%), however, P-αSyn and 5G4, possible markers of later phases, performed better when considering the ankle site alone. A small fiber neuropathy was detected in PD and MSA. A progression of denervation not of pathological αSyn was detected at follow-up and a lower IENFD at baseline was associated with a greater cognitive and motor decline in PD. A skin biopsy-derived compound marker, resulting from a linear discrimination analysis model of αSyn-PLA, P-αSyn, αSyn-5G4, and IENFD, stratified patients with accuracy (77.8%), including the discrimination between PD and MSA (84.6%). In conclusion, the choice of pathological αSyn marker and anatomical site influences the diagnostic performance of skin biopsy and can help in understanding the temporal dynamics of αSyn spreading in the peripheral nervous system during the disease. Skin denervation, not pathological αSyn is a potential progression marker for PD. |
| ArticleNumber | 119 |
| Author | Melli, Giorgia Senese, Camilla Chiaro, Giacomo Disanto, Giulio Kaelin-Lang, Alain Pinton, Sandra Vacchi, Elena Morandi, Sara Bertaina, Ilaria Bianco, Giovanni Gobbi, Claudio Staedler, Claudio Galati, Salvatore |
| Author_xml | – sequence: 1 givenname: Elena orcidid: 0000-0002-8419-277X surname: Vacchi fullname: Vacchi, Elena organization: Laboratory for Biomedical Neurosciences, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Faculty of Biomedical Sciences, Università della Svizzera Italiana – sequence: 2 givenname: Camilla surname: Senese fullname: Senese, Camilla organization: Laboratory for Biomedical Neurosciences, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 3 givenname: Giacomo surname: Chiaro fullname: Chiaro, Giacomo organization: Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 4 givenname: Giulio surname: Disanto fullname: Disanto, Giulio organization: Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 5 givenname: Sandra surname: Pinton fullname: Pinton, Sandra organization: Laboratory for Biomedical Neurosciences, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 6 givenname: Sara surname: Morandi fullname: Morandi, Sara organization: Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 7 givenname: Ilaria surname: Bertaina fullname: Bertaina, Ilaria organization: Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 8 givenname: Giovanni surname: Bianco fullname: Bianco, Giovanni organization: Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 9 givenname: Claudio surname: Staedler fullname: Staedler, Claudio organization: Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 10 givenname: Salvatore surname: Galati fullname: Galati, Salvatore organization: Faculty of Biomedical Sciences, Università della Svizzera Italiana, Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 11 givenname: Claudio surname: Gobbi fullname: Gobbi, Claudio organization: Faculty of Biomedical Sciences, Università della Svizzera Italiana, Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale – sequence: 12 givenname: Alain surname: Kaelin-Lang fullname: Kaelin-Lang, Alain organization: Laboratory for Biomedical Neurosciences, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Department of Neurology, Inselspital, Bern University Hospital, University of Bern – sequence: 13 givenname: Giorgia orcidid: 0000-0003-2069-4620 surname: Melli fullname: Melli, Giorgia email: giorgia.melli@eoc.ch organization: Laboratory for Biomedical Neurosciences, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34930911$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk9vFCEYxiemxtbaL-DBkHjxMsrfGbiYNI1_mjTRg54Jw7zssmVhhZkme-vX8Ov5SWS7rbY99AC8gd_z5AHel81BTBGa5jXB7wlm8kPhRDDSYloHph1tt8-aI8p61kos-oN79WFzUsoKY0x4J5XAL5pDxhXDipCjppyGzdK0ZRtnG8BHlIJfpDXkgkwcUVmbEFCEfAXI-QEy2phpmUJabFGFy2WdTAa0SRPEyZuABp_WJl_uDJJD32vpY0nxz_XvgkZfwBR41Tx3JhQ4uV2Pm5-fP_04-9pefPtyfnZ60VrB8dQqY4zD3QCCYkt77hwX3UgHRiyDXjorRkIUHZXrmWOMd0ZQMrhx7FQ3guDsuDnf-47JrPQm-xpsq5Px-mYj5YU2efL13hoIHrhSnZK945ZbCbazzjhqFe7Bier1ce-1mYc1jLbeNpvwwPThSfRLvUhXWnZSckmqwbtbg5x-zVAmvfbFQggmQpqLph2hTBEhVUXfPkJXac6xPtWOIpISgmWl3txP9C_K3d9WQO4Bm1MpGZy2fjKTT7uAPmiC9a6T9L6TdO0kfdNJelul9JH0zv1JEduLSoXjAvL_2E-o_gJUTt7Y |
| CitedBy_id | crossref_primary_10_1016_j_parkreldis_2025_107772 crossref_primary_10_1016_S1474_4422_25_00194_2 crossref_primary_10_1093_brain_awac161 crossref_primary_10_1093_brain_awac261 crossref_primary_10_1038_s41531_025_01030_y crossref_primary_10_3390_ijms252212176 crossref_primary_10_1002_acn3_51924 crossref_primary_10_3390_ijms25094823 crossref_primary_10_3389_fneur_2024_1510796 crossref_primary_10_3389_fnmol_2024_1431549 crossref_primary_10_1093_jnen_nlae088 crossref_primary_10_1016_j_parkreldis_2023_105956 crossref_primary_10_1016_j_bbr_2022_114204 crossref_primary_10_1371_journal_pone_0276564 crossref_primary_10_3390_cells13100799 crossref_primary_10_1007_s00415_025_12978_5 crossref_primary_10_1186_s42466_024_00354_z crossref_primary_10_1124_pharmrev_122_000674 crossref_primary_10_3233_JPD_223421 crossref_primary_10_1038_s41531_025_01114_9 crossref_primary_10_3390_biology13110893 crossref_primary_10_3390_biom13081263 crossref_primary_10_1038_s41531_024_00728_9 crossref_primary_10_3390_jpm15050172 crossref_primary_10_1007_s13311_022_01287_8 crossref_primary_10_1016_j_parkreldis_2025_107842 crossref_primary_10_1016_j_jns_2023_120730 crossref_primary_10_1016_j_parkreldis_2025_107764 crossref_primary_10_1177_17562864231165561 crossref_primary_10_1002_mds_29419 crossref_primary_10_1093_jnen_nlae015 crossref_primary_10_1177_1877718X251371538 crossref_primary_10_3389_fpubh_2022_861621 crossref_primary_10_3389_fneur_2022_1052137 |
| Cites_doi | 10.1038/s41598-018-32588-8 10.1007/s10286-019-00644-6 10.1111/j.1468-1331.2005.01260.x 10.1007/s00401-010-0664-3 10.1186/s40035-020-00204-3 10.1007/s00401-012-0964-x 10.1016/0022-3956(75)90026-6 10.1016/j.parkreldis.2015.10.019 10.1007/s00702-002-0808-2 10.1002/ana.24648 10.1002/mds.23429 10.1212/WNL.0000000000002919 10.1212/WNL.17.5.427 10.1016/j.nbd.2014.05.020 10.1002/mds.27380 10.1002/mds.27794 10.1038/s41582-020-0333-7 10.1093/brain/awv040 10.1007/978-1-4939-0944-5_27 10.1007/s00401-009-0538-8 10.1111/j.1532-5415.2005.53221.x 10.1093/brain/awaa008 10.1212/WNL.52.6.1269 10.1016/j.parkreldis.2016.01.026 10.1136/jnnp.55.3.181 10.1002/mds.21740 10.1212/WNL.0000000000000316 10.1212/WNL.0b013e31827f0fd1 10.1007/s00401-019-01961-w 10.1016/j.nbd.2020.105086 10.1212/WNL.0000000000009107 10.1212/WNL.0000000000011929 10.1212/01.wnl.0000324625.00404.15 10.1111/j.1468-1331.2010.03023.x 10.3233/JPD-160779 10.1002/mds.28126 10.1212/WNL.0000000000011935 10.1002/mds.26987 10.1007/s00702-017-1692-0 10.1007/s00401-018-1876-1 10.1002/mds.26293 10.1016/j.mayocp.2012.10.013 10.1002/mds.23838 10.1007/s00401-017-1755-1 10.1111/nan.12486 10.1007/s00401-010-0665-2 10.1038/nrneurol.2017.26 10.1002/acn3.669 10.1111/j.1749-6632.2000.tb06900.x 10.1111/ene.12842 10.3791/59558 10.1037/t00742-000 10.1093/sleep/zsy101 10.3233/JPD-202489 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 2021. The Author(s). The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2021 – notice: 2021. The Author(s). – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1038/s41531-021-00262-y |
| DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database CrossRef PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2373-8057 |
| EndPage | 11 |
| ExternalDocumentID | oai_doaj_org_article_e10b4996987f4c4c8ec6cfaf2c907ef5 PMC8688481 34930911 10_1038_s41531_021_00262_y |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: FIDINAM 05.2020 – fundername: FIDINAL 05.2020 – fundername: ; |
| GroupedDBID | 0R~ 3V. 53G 5VS 7X7 8FI 8FJ AAJSJ ABUWG ACGFS ACSMW ADBBV AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV BENPR BPHCQ BVXVI C6C CCPQU EBLON EBS EMOBN FYUFA GROUPED_DOAJ HMCUK HYE M~E NAO NO~ OK1 PGMZT PIMPY PQQKQ PROAC RNT RPM SNYQT UKHRP AASML AAYXX CITATION NPM 7XB 8FK AZQEC DWQXO K9. PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c540t-9aaaf06be520c274ff456d2b31c3e78fc5d1192d9f73f3346a521bfdd696de543 |
| IEDL.DBID | 7X7 |
| ISICitedReferencesCount | 39 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000732939600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2373-8057 |
| IngestDate | Tue Oct 14 19:05:54 EDT 2025 Tue Nov 04 01:35:02 EST 2025 Sun Nov 09 13:19:22 EST 2025 Sat Nov 29 14:27:54 EST 2025 Mon Jul 21 06:09:31 EDT 2025 Sat Nov 29 02:57:32 EST 2025 Tue Nov 18 21:08:05 EST 2025 Fri Feb 21 02:40:28 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2021. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c540t-9aaaf06be520c274ff456d2b31c3e78fc5d1192d9f73f3346a521bfdd696de543 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-8419-277X 0000-0003-2069-4620 |
| OpenAccessLink | https://www.proquest.com/docview/2611821108?pq-origsite=%requestingapplication% |
| PMID | 34930911 |
| PQID | 2611821108 |
| PQPubID | 2041921 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_e10b4996987f4c4c8ec6cfaf2c907ef5 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8688481 proquest_miscellaneous_2612391589 proquest_journals_2611821108 pubmed_primary_34930911 crossref_citationtrail_10_1038_s41531_021_00262_y crossref_primary_10_1038_s41531_021_00262_y springer_journals_10_1038_s41531_021_00262_y |
| PublicationCentury | 2000 |
| PublicationDate | 2021-12-20 |
| PublicationDateYYYYMMDD | 2021-12-20 |
| PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-20 day: 20 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: United States |
| PublicationTitle | NPJ Parkinson's Disease |
| PublicationTitleAbbrev | npj Parkinsons Dis |
| PublicationTitleAlternate | NPJ Parkinsons Dis |
| PublicationYear | 2021 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Sekiya (CR27) 2019; 137 Nasreddine (CR51) 2005; 53 Melli (CR14) 2018; 5 Hoehn, Yahr (CR48) 1967; 17 Kovacs (CR17) 2012; 124 CR34 Klingelhoefer, Reichmann (CR3) 2017; 124 Stokholm, Danielsen, Hamilton-Dutoit, Borghammer (CR9) 2016; 79 Gilman (CR45) 2008; 71 Sletten, Suarez, Low, Mandrekar, Singer (CR52) 2012; 87 Braak, Rub, Gai, Del Tredici (CR31) 2003; 110 Peng, Trojanowski, Lee (CR33) 2020; 16 Provitera (CR57) 2016; 23 Gibbons, Garcia, Wang, Shih, Freeman (CR13) 2016; 87 Lauria (CR42) 2005; 12 Nolano (CR22) 2018; 136 Hoglinger (CR46) 2017; 32 Donadio (CR11) 2014; 82 Che, Yang (CR39) 2020; 9 Mazzetti (CR29) 2020; 143 CR49 Kumar (CR18) 2020; 146 Armstrong (CR47) 2013; 80 Hughes, Daniel, Kilford, Lees (CR44) 1992; 55 Shannon (CR7) 2012; 27 Roberts, Wade-Martins, Alegre-Abarrategui (CR25) 2015; 138 Kumaresan, Khan (CR4) 2021; 13 Bengoa-Vergniory, Roberts, Wade-Martins, Alegre-Abarrategui (CR26) 2017; 134 Iwanaga (CR15) 1999; 52 Doppler (CR12) 2015; 30 CR19 Lee (CR6) 2017; 76 Beach (CR30) 2009; 117 Bellucci, Fiorentini, Zaltieri, Missale, Spano (CR24) 2014; 1174 Kovacs (CR16) 2014; 69 CR56 CR53 Del Tredici, Hawkes, Ghebremedhin, Braak (CR10) 2010; 119 Donadio (CR37) 2021; 96 Irwin, Saint-Hilaire (CR8) 2021; 96 Donadio (CR32) 2018; 8 Cossu, Melis (CR40) 2016; 25 Isonaka, Gibbons, Wang, Freeman, Goldstein (CR36) 2019; 29 Beach (CR5) 2010; 119 Stiasny-Kolster (CR54) 2007; 22 Lauria (CR43) 2010; 17 Spillantini, Goedert (CR1) 2000; 920 Krismer, Wenning (CR2) 2017; 13 Skorvanek (CR20) 2018; 33 Espay (CR41) 2020; 94 Tsukita, Sakamaki-Tsukita, Tanaka, Suenaga, Takahashi (CR21) 2019; 34 Kass-Iliyya (CR23) 2015; 21 Donadio (CR38) 2020; 35 Folstein, Folstein, McHugh (CR50) 1975; 12 Ruffmann (CR28) 2018; 44 Tomlinson (CR55) 2010; 25 Oueslati (CR35) 2016; 6 H Sekiya (262_CR27) 2019; 137 S Gilman (262_CR45) 2008; 71 AJ Hughes (262_CR44) 1992; 55 L Klingelhoefer (262_CR3) 2017; 124 CL Tomlinson (262_CR55) 2010; 25 MG Spillantini (262_CR1) 2000; 920 K Stiasny-Kolster (262_CR54) 2007; 22 V Provitera (262_CR57) 2016; 23 K Iwanaga (262_CR15) 1999; 52 A Bellucci (262_CR24) 2014; 1174 M Skorvanek (262_CR20) 2018; 33 GG Kovacs (262_CR16) 2014; 69 F Krismer (262_CR2) 2017; 13 G Lauria (262_CR42) 2005; 12 MF Folstein (262_CR50) 1975; 12 RF Roberts (262_CR25) 2015; 138 TG Beach (262_CR5) 2010; 119 D Irwin (262_CR8) 2021; 96 M Nolano (262_CR22) 2018; 136 V Donadio (262_CR37) 2021; 96 K Del Tredici (262_CR10) 2010; 119 AJ Espay (262_CR41) 2020; 94 ZS Nasreddine (262_CR51) 2005; 53 262_CR56 V Donadio (262_CR32) 2018; 8 K Tsukita (262_CR21) 2019; 34 CH Gibbons (262_CR13) 2016; 87 262_CR19 C Peng (262_CR33) 2020; 16 MM Hoehn (262_CR48) 1967; 17 V Donadio (262_CR38) 2020; 35 GU Hoglinger (262_CR46) 2017; 32 262_CR53 TG Beach (262_CR30) 2009; 117 H Braak (262_CR31) 2003; 110 262_CR49 K Doppler (262_CR12) 2015; 30 G Lauria (262_CR43) 2010; 17 N Bengoa-Vergniory (262_CR26) 2017; 134 G Melli (262_CR14) 2018; 5 GG Kovacs (262_CR17) 2012; 124 JM Lee (262_CR6) 2017; 76 C Ruffmann (262_CR28) 2018; 44 G Cossu (262_CR40) 2016; 25 MJ Armstrong (262_CR47) 2013; 80 S Mazzetti (262_CR29) 2020; 143 M Kumaresan (262_CR4) 2021; 13 ST Kumar (262_CR18) 2020; 146 L Kass-Iliyya (262_CR23) 2015; 21 A Oueslati (262_CR35) 2016; 6 KM Shannon (262_CR7) 2012; 27 V Donadio (262_CR11) 2014; 82 DM Sletten (262_CR52) 2012; 87 NN Che (262_CR39) 2020; 9 R Isonaka (262_CR36) 2019; 29 262_CR34 MG Stokholm (262_CR9) 2016; 79 |
| References_xml | – volume: 8 year: 2018 ident: CR32 article-title: Skin alpha-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study publication-title: Sci. Rep. doi: 10.1038/s41598-018-32588-8 – volume: 29 start-page: 587 year: 2019 end-page: 593 ident: CR36 article-title: Association of innervation-adjusted alpha-synuclein in arrector pili muscles with cardiac noradrenergic deficiency in autonomic synucleinopathies publication-title: Clin. Auton. Res. doi: 10.1007/s10286-019-00644-6 – volume: 12 start-page: 747 year: 2005 end-page: 758 ident: CR42 article-title: EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy publication-title: Eur. J. Neurol. doi: 10.1111/j.1468-1331.2005.01260.x – ident: CR49 – volume: 119 start-page: 689 year: 2010 end-page: 702 ident: CR5 article-title: Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders publication-title: Acta Neuropathol. doi: 10.1007/s00401-010-0664-3 – volume: 9 start-page: 28 year: 2020 ident: CR39 article-title: Potential use of corneal confocal microscopy in the diagnosis of Parkinson’s disease associated neuropathy publication-title: Transl. Neurodegener. doi: 10.1186/s40035-020-00204-3 – volume: 124 start-page: 37 year: 2012 end-page: 50 ident: CR17 article-title: An antibody with high reactivity for disease-associated alpha-synuclein reveals extensive brain pathology publication-title: Acta Neuropathol. doi: 10.1007/s00401-012-0964-x – volume: 12 start-page: 189 year: 1975 end-page: 198 ident: CR50 article-title: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician publication-title: J. Psychiatr. Res. doi: 10.1016/0022-3956(75)90026-6 – volume: 21 start-page: 1454 year: 2015 end-page: 1460 ident: CR23 article-title: Small fiber neuropathy in Parkinson’s disease: a clinical, pathological and corneal confocal microscopy study publication-title: Parkinsonism Relat. Disord. doi: 10.1016/j.parkreldis.2015.10.019 – volume: 110 start-page: 517 year: 2003 end-page: 536 ident: CR31 article-title: Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen publication-title: J. Neural Transm. doi: 10.1007/s00702-002-0808-2 – volume: 79 start-page: 940 year: 2016 end-page: 949 ident: CR9 article-title: Pathological alpha-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients publication-title: Ann. Neurol. doi: 10.1002/ana.24648 – volume: 25 start-page: 2649 year: 2010 end-page: 2653 ident: CR55 article-title: Systematic review of levodopa dose equivalency reporting in Parkinson’s disease publication-title: Mov. Disord. doi: 10.1002/mds.23429 – volume: 87 start-page: 505 year: 2016 end-page: 512 ident: CR13 article-title: The diagnostic discrimination of cutaneous alpha-synuclein deposition in Parkinson disease publication-title: Neurology doi: 10.1212/WNL.0000000000002919 – volume: 17 start-page: 427 year: 1967 end-page: 442 ident: CR48 article-title: Parkinsonism: onset, progression and mortality publication-title: Neurology doi: 10.1212/WNL.17.5.427 – volume: 69 start-page: 76 year: 2014 end-page: 92 ident: CR16 article-title: Intracellular processing of disease-associated alpha-synuclein in the human brain suggests prion-like cell-to-cell spread publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2014.05.020 – volume: 33 start-page: 1366 year: 2018 end-page: 1368 ident: CR20 article-title: alpha-Synuclein antibody 5G4 identifies manifest and prodromal Parkinson’s disease in colonic mucosa publication-title: Mov. Disord. doi: 10.1002/mds.27380 – volume: 34 start-page: 1452 year: 2019 end-page: 1463 ident: CR21 article-title: Value of in vivo alpha-synuclein deposits in Parkinson’s disease: a systematic review and meta-analysis publication-title: Mov. Disord. doi: 10.1002/mds.27794 – ident: CR19 – volume: 16 start-page: 199 year: 2020 end-page: 212 ident: CR33 article-title: Protein transmission in neurodegenerative disease publication-title: Nat. Rev. Neurol. doi: 10.1038/s41582-020-0333-7 – volume: 138 start-page: 1642 year: 2015 end-page: 1657 ident: CR25 article-title: Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease publication-title: Brain. Brain doi: 10.1093/brain/awv040 – volume: 1174 start-page: 397 year: 2014 end-page: 405 ident: CR24 article-title: The “in situ” proximity ligation assay to probe protein-protein interactions in intact tissues publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-0944-5_27 – volume: 117 start-page: 613 year: 2009 end-page: 634 ident: CR30 article-title: Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction publication-title: Acta Neuropathol. doi: 10.1007/s00401-009-0538-8 – volume: 53 start-page: 695 year: 2005 end-page: 699 ident: CR51 article-title: The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment publication-title: J. Am. Geriatr. Soc. doi: 10.1111/j.1532-5415.2005.53221.x – volume: 76 start-page: 2 year: 2017 end-page: 15 ident: CR6 article-title: The search for a peripheral biopsy indicator of alpha-synuclein pathology for Parkinson disease publication-title: J. Neuropathol. Exp. Neurol. – volume: 143 start-page: 920 year: 2020 end-page: 931 ident: CR29 article-title: alpha-Synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson’s disease publication-title: Brain doi: 10.1093/brain/awaa008 – volume: 52 start-page: 1269 year: 1999 end-page: 1271 ident: CR15 article-title: Lewy body-type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases publication-title: Neurology doi: 10.1212/WNL.52.6.1269 – volume: 25 start-page: 17 year: 2016 end-page: 20 ident: CR40 article-title: The peripheral nerve involvement in Parkinson disease: a multifaceted phenomenon publication-title: Parkinsonism Relat. Disord. doi: 10.1016/j.parkreldis.2016.01.026 – volume: 13 start-page: e13275 year: 2021 ident: CR4 article-title: Spectrum of non-motor symptoms in Parkinson’s disease publication-title: Cureus – volume: 55 start-page: 181 year: 1992 end-page: 184 ident: CR44 article-title: Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp.55.3.181 – volume: 22 start-page: 2386 year: 2007 end-page: 2393 ident: CR54 article-title: The REM sleep behavior disorder screening questionnaire - A new diagnostic instrument publication-title: Mov. Disord. doi: 10.1002/mds.21740 – volume: 82 start-page: 1362 year: 2014 end-page: 1369 ident: CR11 article-title: Skin nerve alpha-synuclein deposits: a biomarker for idiopathic Parkinson disease publication-title: Neurology doi: 10.1212/WNL.0000000000000316 – volume: 80 start-page: 496 year: 2013 end-page: 503 ident: CR47 article-title: Criteria for the diagnosis of corticobasal degeneration publication-title: Neurology doi: 10.1212/WNL.0b013e31827f0fd1 – ident: CR53 – volume: 137 start-page: 455 year: 2019 end-page: 466 ident: CR27 article-title: Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation publication-title: Acta Neuropathol. doi: 10.1007/s00401-019-01961-w – volume: 146 start-page: 105086 year: 2020 ident: CR18 article-title: How specific are the conformation-specific alpha-synuclein antibodies? Characterization and validation of 16 alpha-synuclein conformation-specific antibodies using well-characterized preparations of alpha-synuclein monomers, fibrils and oligomers with distinct structures and morphology publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2020.105086 – volume: 94 start-page: 481 year: 2020 end-page: 494 ident: CR41 article-title: Disease modification and biomarker development in Parkinson disease: revision or reconstruction? publication-title: Neurology doi: 10.1212/WNL.0000000000009107 – volume: 96 start-page: 925 year: 2021 end-page: 926 ident: CR8 article-title: In vivo detection of underlying synucleinopathies: are we there yet? publication-title: Neurology doi: 10.1212/WNL.0000000000011929 – volume: 71 start-page: 670 year: 2008 end-page: 676 ident: CR45 article-title: Second consensus statement on the diagnosis of multiple system atrophy publication-title: Neurology doi: 10.1212/01.wnl.0000324625.00404.15 – ident: CR56 – volume: 17 start-page: 903 year: 2010 end-page: 912 ident: CR43 article-title: European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society publication-title: Eur. J. Neurol. doi: 10.1111/j.1468-1331.2010.03023.x – volume: 6 start-page: 39 year: 2016 end-page: 51 ident: CR35 article-title: Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade? publication-title: J. Parkinsons Dis. doi: 10.3233/JPD-160779 – volume: 35 start-page: 1649 year: 2020 end-page: 1657 ident: CR38 article-title: Skin biopsy may help to distinguish multiple system atrophy-Parkinsonism from Parkinson’s disease with orthostatic hypotension publication-title: Mov. Disord. doi: 10.1002/mds.28126 – volume: 96 start-page: e2513 year: 2021 end-page: e2524 ident: CR37 article-title: In vivo diagnosis of synucleinopathies: a comparative study of skin biopsy and RT-QuIC publication-title: Neurology doi: 10.1212/WNL.0000000000011935 – volume: 32 start-page: 853 year: 2017 end-page: 864 ident: CR46 article-title: Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria publication-title: Mov. Disord. doi: 10.1002/mds.26987 – volume: 124 start-page: 709 year: 2017 end-page: 713 ident: CR3 article-title: Parkinson’s disease as a multisystem disorder publication-title: J. Neural Transm. doi: 10.1007/s00702-017-1692-0 – volume: 136 start-page: 501 year: 2018 end-page: 503 ident: CR22 article-title: Small fiber pathology parallels disease progression in Parkinson disease: a longitudinal study publication-title: Acta Neuropathol. doi: 10.1007/s00401-018-1876-1 – volume: 30 start-page: 1688 year: 2015 end-page: 1692 ident: CR12 article-title: Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy publication-title: Mov. Disord. doi: 10.1002/mds.26293 – volume: 87 start-page: 1196 year: 2012 end-page: 1201 ident: CR52 article-title: COMPASS 31: a refined and abbreviated composite autonomic symptom score publication-title: Mayo Clin. Proc. doi: 10.1016/j.mayocp.2012.10.013 – volume: 27 start-page: 709 year: 2012 end-page: 715 ident: CR7 article-title: Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease publication-title: Mov. Disord. doi: 10.1002/mds.23838 – volume: 134 start-page: 819 year: 2017 end-page: 838 ident: CR26 article-title: Alpha-synuclein oligomers: a new hope publication-title: Acta Neuropathol. doi: 10.1007/s00401-017-1755-1 – volume: 44 start-page: 722 year: 2018 end-page: 736 ident: CR28 article-title: Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson’s disease publication-title: Neuropathol. Appl. Neurobiol. doi: 10.1111/nan.12486 – volume: 119 start-page: 703 year: 2010 end-page: 713 ident: CR10 article-title: Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease publication-title: Acta Neuropathol. doi: 10.1007/s00401-010-0665-2 – volume: 13 start-page: 232 year: 2017 end-page: 243 ident: CR2 article-title: Multiple system atrophy: insights into a rare and debilitating movement disorder publication-title: Nat. Rev. Neurol. doi: 10.1038/nrneurol.2017.26 – volume: 5 start-page: 1394 year: 2018 end-page: 1407 ident: CR14 article-title: Cervical skin denervation associates with alpha-synuclein aggregates in Parkinson disease publication-title: Ann. Clin. Transl. Neurol. doi: 10.1002/acn3.669 – ident: CR34 – volume: 920 start-page: 16 year: 2000 end-page: 27 ident: CR1 article-title: The alpha-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy publication-title: Ann. N. Y Acad. Sci. doi: 10.1111/j.1749-6632.2000.tb06900.x – volume: 23 start-page: 333 year: 2016 end-page: 338 ident: CR57 article-title: A multi-center, multinational age- and gender-adjusted normative dataset for immunofluorescent intraepidermal nerve fiber density at the distal leg publication-title: Eur. J. Neurol. doi: 10.1111/ene.12842 – volume: 138 start-page: 1642 year: 2015 ident: 262_CR25 publication-title: Brain. Brain doi: 10.1093/brain/awv040 – volume: 17 start-page: 903 year: 2010 ident: 262_CR43 publication-title: Eur. J. Neurol. doi: 10.1111/j.1468-1331.2010.03023.x – volume: 53 start-page: 695 year: 2005 ident: 262_CR51 publication-title: J. Am. Geriatr. Soc. doi: 10.1111/j.1532-5415.2005.53221.x – volume: 94 start-page: 481 year: 2020 ident: 262_CR41 publication-title: Neurology doi: 10.1212/WNL.0000000000009107 – volume: 920 start-page: 16 year: 2000 ident: 262_CR1 publication-title: Ann. N. Y Acad. Sci. doi: 10.1111/j.1749-6632.2000.tb06900.x – volume: 21 start-page: 1454 year: 2015 ident: 262_CR23 publication-title: Parkinsonism Relat. Disord. doi: 10.1016/j.parkreldis.2015.10.019 – volume: 44 start-page: 722 year: 2018 ident: 262_CR28 publication-title: Neuropathol. Appl. Neurobiol. doi: 10.1111/nan.12486 – volume: 35 start-page: 1649 year: 2020 ident: 262_CR38 publication-title: Mov. Disord. doi: 10.1002/mds.28126 – volume: 87 start-page: 505 year: 2016 ident: 262_CR13 publication-title: Neurology doi: 10.1212/WNL.0000000000002919 – volume: 12 start-page: 189 year: 1975 ident: 262_CR50 publication-title: J. Psychiatr. Res. doi: 10.1016/0022-3956(75)90026-6 – volume: 69 start-page: 76 year: 2014 ident: 262_CR16 publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2014.05.020 – volume: 23 start-page: 333 year: 2016 ident: 262_CR57 publication-title: Eur. J. Neurol. doi: 10.1111/ene.12842 – volume: 76 start-page: 2 year: 2017 ident: 262_CR6 publication-title: J. Neuropathol. Exp. Neurol. – volume: 124 start-page: 37 year: 2012 ident: 262_CR17 publication-title: Acta Neuropathol. doi: 10.1007/s00401-012-0964-x – ident: 262_CR56 doi: 10.3791/59558 – volume: 16 start-page: 199 year: 2020 ident: 262_CR33 publication-title: Nat. Rev. Neurol. doi: 10.1038/s41582-020-0333-7 – volume: 29 start-page: 587 year: 2019 ident: 262_CR36 publication-title: Clin. Auton. Res. doi: 10.1007/s10286-019-00644-6 – volume: 17 start-page: 427 year: 1967 ident: 262_CR48 publication-title: Neurology doi: 10.1212/WNL.17.5.427 – volume: 143 start-page: 920 year: 2020 ident: 262_CR29 publication-title: Brain doi: 10.1093/brain/awaa008 – volume: 146 start-page: 105086 year: 2020 ident: 262_CR18 publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2020.105086 – volume: 9 start-page: 28 year: 2020 ident: 262_CR39 publication-title: Transl. Neurodegener. doi: 10.1186/s40035-020-00204-3 – ident: 262_CR49 – volume: 55 start-page: 181 year: 1992 ident: 262_CR44 publication-title: J. Neurol. Neurosurg. Psychiatry doi: 10.1136/jnnp.55.3.181 – volume: 80 start-page: 496 year: 2013 ident: 262_CR47 publication-title: Neurology doi: 10.1212/WNL.0b013e31827f0fd1 – volume: 79 start-page: 940 year: 2016 ident: 262_CR9 publication-title: Ann. Neurol. doi: 10.1002/ana.24648 – volume: 5 start-page: 1394 year: 2018 ident: 262_CR14 publication-title: Ann. Clin. Transl. Neurol. doi: 10.1002/acn3.669 – volume: 1174 start-page: 397 year: 2014 ident: 262_CR24 publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-0944-5_27 – volume: 32 start-page: 853 year: 2017 ident: 262_CR46 publication-title: Mov. Disord. doi: 10.1002/mds.26987 – volume: 117 start-page: 613 year: 2009 ident: 262_CR30 publication-title: Acta Neuropathol. doi: 10.1007/s00401-009-0538-8 – volume: 136 start-page: 501 year: 2018 ident: 262_CR22 publication-title: Acta Neuropathol. doi: 10.1007/s00401-018-1876-1 – volume: 87 start-page: 1196 year: 2012 ident: 262_CR52 publication-title: Mayo Clin. Proc. doi: 10.1016/j.mayocp.2012.10.013 – volume: 96 start-page: e2513 year: 2021 ident: 262_CR37 publication-title: Neurology doi: 10.1212/WNL.0000000000011935 – volume: 25 start-page: 17 year: 2016 ident: 262_CR40 publication-title: Parkinsonism Relat. Disord. doi: 10.1016/j.parkreldis.2016.01.026 – volume: 25 start-page: 2649 year: 2010 ident: 262_CR55 publication-title: Mov. Disord. doi: 10.1002/mds.23429 – volume: 52 start-page: 1269 year: 1999 ident: 262_CR15 publication-title: Neurology doi: 10.1212/WNL.52.6.1269 – ident: 262_CR53 doi: 10.1037/t00742-000 – volume: 82 start-page: 1362 year: 2014 ident: 262_CR11 publication-title: Neurology doi: 10.1212/WNL.0000000000000316 – volume: 22 start-page: 2386 year: 2007 ident: 262_CR54 publication-title: Mov. Disord. doi: 10.1002/mds.21740 – volume: 6 start-page: 39 year: 2016 ident: 262_CR35 publication-title: J. Parkinsons Dis. doi: 10.3233/JPD-160779 – volume: 8 year: 2018 ident: 262_CR32 publication-title: Sci. Rep. doi: 10.1038/s41598-018-32588-8 – volume: 119 start-page: 689 year: 2010 ident: 262_CR5 publication-title: Acta Neuropathol. doi: 10.1007/s00401-010-0664-3 – volume: 137 start-page: 455 year: 2019 ident: 262_CR27 publication-title: Acta Neuropathol. doi: 10.1007/s00401-019-01961-w – volume: 71 start-page: 670 year: 2008 ident: 262_CR45 publication-title: Neurology doi: 10.1212/01.wnl.0000324625.00404.15 – volume: 34 start-page: 1452 year: 2019 ident: 262_CR21 publication-title: Mov. Disord. doi: 10.1002/mds.27794 – ident: 262_CR19 doi: 10.1093/sleep/zsy101 – volume: 124 start-page: 709 year: 2017 ident: 262_CR3 publication-title: J. Neural Transm. doi: 10.1007/s00702-017-1692-0 – volume: 30 start-page: 1688 year: 2015 ident: 262_CR12 publication-title: Mov. Disord. doi: 10.1002/mds.26293 – volume: 110 start-page: 517 year: 2003 ident: 262_CR31 publication-title: J. Neural Transm. doi: 10.1007/s00702-002-0808-2 – volume: 13 start-page: 232 year: 2017 ident: 262_CR2 publication-title: Nat. Rev. Neurol. doi: 10.1038/nrneurol.2017.26 – volume: 33 start-page: 1366 year: 2018 ident: 262_CR20 publication-title: Mov. Disord. doi: 10.1002/mds.27380 – volume: 96 start-page: 925 year: 2021 ident: 262_CR8 publication-title: Neurology doi: 10.1212/WNL.0000000000011929 – volume: 12 start-page: 747 year: 2005 ident: 262_CR42 publication-title: Eur. J. Neurol. doi: 10.1111/j.1468-1331.2005.01260.x – volume: 13 start-page: e13275 year: 2021 ident: 262_CR4 publication-title: Cureus – volume: 134 start-page: 819 year: 2017 ident: 262_CR26 publication-title: Acta Neuropathol. doi: 10.1007/s00401-017-1755-1 – volume: 119 start-page: 703 year: 2010 ident: 262_CR10 publication-title: Acta Neuropathol. doi: 10.1007/s00401-010-0665-2 – ident: 262_CR34 doi: 10.3233/JPD-202489 – volume: 27 start-page: 709 year: 2012 ident: 262_CR7 publication-title: Mov. Disord. doi: 10.1002/mds.23838 |
| SSID | ssj0001468950 |
| Score | 2.3666463 |
| Snippet | The proximity ligation assay (PLA) is a specific and sensitive technique for the detection of αSyn oligomers (αSyn-PLA), early and toxic species implicated in... Abstract The proximity ligation assay (PLA) is a specific and sensitive technique for the detection of αSyn oligomers (αSyn-PLA), early and toxic species... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 119 |
| SubjectTerms | 692/53/2421 692/699/375/1718 Accuracy Ankle Biomarkers Biomedical and Life Sciences Biomedicine Biopsy Demographics Localization Longitudinal studies Monoclonal antibodies Neurology Neurosciences Parkinson's disease Pathology |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hCiEuqLxDCzISN4ia2IljHwui4kLFAaTeLMcPWLEk1WaLtLf-jf69_pLOONmly_PCZQ8b7-7IM96ZzzPzDcCLOiCsKrnMubYirwIVAaCjzGu0Fl-HgIisSsMmmuNjdXKiP1wb9UU1YSM98LhxB6EsWozKJWLjWLnKqeCkizZyh7AuxMReWjT6GphKtyuVVLoupi6ZQqiDAT2VQOSMwhDu4PlqyxMlwv7fRZm_Fkv-lDFNjuhoF-5MESQ7HCW_CzdCdw9uvZ9y5PdhOKT22XxYdURVPOtYP5997ul6mtnOs-Gbnc9ZR4WOLFK5CKOhxOlyneHi4Su-2EVgp_2SConwl6hDn4p48Av6yKhNOnWMXZ5fDGzK7zyAT0dvP755l0-jFXKHIdoy19baWMg21LxwCExjxEDK81aUToRGRVf7EmM_r2MjohCVtOjm2-i91NKHuhIPYafru_AYWI0uv1E6ONV4mvpri1joaNtSFkG2XGRQrrfZuIl3nMZfzE3KfwtlRtUYVI1JqjGrDF5uPnM6sm78dfVr0t5mJTFmpzfQjsxkR-ZfdpTB_lr3ZjrGg0F4ifiLOiUyeL55jAeQsiq2C_1ZWsOJZV_pDB6NprKRRFRaYEBWZtBsGdGWqNtPutmXRPKtpKJJBxm8WpvbD7H-vBVP_sdW7MFtTuek5Pgfug87y8VZeAo33fflbFg8SwftCssnLfA priority: 102 providerName: Directory of Open Access Journals |
| Title | Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson’s disease |
| URI | https://link.springer.com/article/10.1038/s41531-021-00262-y https://www.ncbi.nlm.nih.gov/pubmed/34930911 https://www.proquest.com/docview/2611821108 https://www.proquest.com/docview/2612391589 https://pubmed.ncbi.nlm.nih.gov/PMC8688481 https://doaj.org/article/e10b4996987f4c4c8ec6cfaf2c907ef5 |
| Volume | 7 |
| WOSCitedRecordID | wos000732939600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2373-8057 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001468950 issn: 2373-8057 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2373-8057 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001468950 issn: 2373-8057 databaseCode: M~E dateStart: 20150101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jj9MwFLZgBqG5sC-BoTISN4gmiRMvJzSDOoJDqwqBVE6R49gzFSXpNB2kXhB_g7_HL-E9121Vlrlw8SFxEjvv2f7eTsiLwoJYlWY8zpRmcW7RCQAOyrgAbqkLa0Eiy32xCTEcyvFYjYLCrQtules90W_UdWtQR34ESB-gMDqtv55dxFg1Cq2roYTGdbKPZbORz8VYbHUsOZeqSEKsTMLkUQfnFQP5GYaE0kcWL3fOI5-2_29Y80-Xyd_spv44Or39vxO5Q24FIEqPV5xzl1yzzT1ycxBM7fdJd4xRuHG3bDDj8aSh7XRy1qKWm-qmpt0XPZ3SBv0lqUOvE4q1jb2OnkLn7jM0em7prF2gPxJ8CQP90RcIXtA6itHWPvDs5_cfHQ1mogfk42n_w5u3cajQEBtAeotYaa1dwitbZIkB-dY5wGN1VrHUMCukM0WdAoSslRPMMZZzDWihcnXNFa9tkbOHZK9pG_uY0AKQg5DKGilqLB6sE5cop6uUJ5ZXGYtIuqZTaUL6cqyiMS29GZ3JckXbEmhbetqWy4i83DwzWyXvuLL3CZJ_0xMTb_sL7fysDOu4tGlSgZDIlRQuN7mR1nDjtMuMSoR1RUQO11Qvw27QlVuSR-T55jasYzTO6Ma2l75Phsn6pYrIoxWvbUbCcsUA16URETtcuDPU3TvN5NznCpdcYsGEiLxa8-t2WP_-FU-unsVTcpDhEkoz2GQPyd5ifmmfkRvm62LSzXt-DfpW9sj-SX84et_zqg5oB9_6cG30bjD69At1s0EZ |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lc9MwEN4phQEuvB-GAmIGTuCpLfkhHRimPDrttM1wKDO5ubIslQzBDnEKkxt_gz_Bj-KXsKs4yYRHbz1wySFWHFn-9qX9tAvwJLUYVsU8C7nSIkwskQDQUIYpoqVKrcWILPHNJvJeT_b76t0a_JifhSFa5VwnekVdNYb2yDfR00dXmEjrL0efQ-oaRdnVeQuNGSz27PQrhmzti903-H6fcr799vD1Tth1FQgNeieTUGmtXZSVNuWRwZjMOfQhKl6K2AibS2fSKka3p1IuF06IJNNo4UpXVZnKKpsmAu97Ds6jHs8p2Mv7-XJPJ8mkSqPubE4k5GaL9lFgvI5LQNEOD6cr9s-3Cfibb_snRfO3PK03f9tX_7eFuwZXOkebbc0k4zqs2foGXDzoqAQ3od2iU8ZhO62povOgZs1wcNzQLj7TdcXaT3o4ZDXxQZkjVg2j3s0-B8FwcPsRP_TYslEzIb4V_hMVMiCuE96gcYxOk_uDdT-_fW9Zlwa7Be_P5JFvw3rd1PYusBQ9o1wqa2ReUXNkHblIOV3GWWSzkosA4jkuCtOVZ6cuIcPC0wSELGZYKhBLhcdSMQ3g2eI3o1lxklNHvyK4LUZSYXH_RTM-Ljo9Vdg4KjEIzpTMXWISI63JjNOOGxXl1qUBbMxRVnTari2WEAvg8eIy6ilKPunaNid-DKdmBFIFcGeG7cVMRKIE-q1xAPkK6lemunqlHnzwtdBlJqkhRADP5_KxnNa_l-Le6U_xCC7tHB7sF_u7vb37cJmT-MYcDcoGrE_GJ_YBXDBfJoN2_NDLP4Ojs5abX5-emIQ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lj9MwEB4tXbTiwvsRWMBIcIKoiZ2HfUBoYamolq16AGk5Bcexl4qSlKYL6o2_wV_h5_BLmEnTVuWxtz1w6aFxU8eZxzeezzMAD2OLYVXIE58rLfzIEgkAHaUfo7QUsbUYkUVNs4l0MJBHR2q4BT-WZ2GIVrm0iY2hLipDe-RdRPoIhYm03nUtLWK433s2-exTBynKtC7baSxE5MDOv2L4Vj_t7-O7fsR57-WbF6_8tsOAbxCpzHyltXZBktuYBwbjM-cQTxQ8F6ERNpXOxEWIEKhQLhVOiCjR6O1yVxSJSgobRwLvew62EZJHvAPbw_7h8N16hydKpIqD9qROIGS3Rm8pMHrHBaHYh_vzDW_YNA34G9L9k7D5W9a2cYa9S__zMl6Giy0EZ3sLnbkCW7a8CjuHLcngGtR7dP7Yr-cl1Xoelawaj44r2t9nuixY_UmPx6wkpihzxLdh1NW5yU4wHFx_xA89tWxSzYiJhf9EJQ6IBYU3qByjc-bNkbuf377XrE2QXYe3Z_LIN6BTVqW9BSxGzJRKZY1MC2qbrAMXKKfzMAlsknPhQbiUkcy0hdupf8g4awgEQmYLucpQrrJGrrK5B49Xv5ksypacOvo5id5qJJUcb76opsdZa8EyGwY5hseJkqmLTGSkNYlx2nGjgtS62IPdpcRlrR2ss7W4efBgdRktGKWldGmrk2YMpzYFUnlwcyHnq5mISAlEtKEH6YYGbEx180o5-tBUSZeJpFYRHjxZ6sp6Wv9eitunP8V92EF1yV73Bwd34AInTQ45eppd6MymJ_YunDdfZqN6eq81Bgzen7Xi_ALil6LT |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alpha-synuclein+oligomers+and+small+nerve+fiber+pathology+in+skin+are+potential+biomarkers+of+Parkinson%27s+disease&rft.jtitle=NPJ+Parkinson%27s+Disease&rft.au=Vacchi%2C+Elena&rft.au=Senese%2C+Camilla&rft.au=Chiaro%2C+Giacomo&rft.au=Disanto%2C+Giulio&rft.date=2021-12-20&rft.issn=2373-8057&rft.eissn=2373-8057&rft.volume=7&rft.issue=1&rft.spage=119&rft_id=info:doi/10.1038%2Fs41531-021-00262-y&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2373-8057&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2373-8057&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2373-8057&client=summon |